Highlights
NASDAQ: PSTI       Pluristem Therapeutc
Last Price Today's Change   Day's Range   Trading Volume
3.20   -0.05 (1.54%)  3.17 - 3.31  37,341

Overview

 
Avg Volume (4 weeks):70,910
4 Weeks Range:3.17 - 4.05
4 Weeks Price Volatility (%):
3.41%
52 Weeks Range:0.397 - 5.93
52 Weeks Price Volatility (%):
50.66%
Average Price Target: 5.00
Price Target Upside/Downside: +1.80

Headlines



No recent Headlines for this stock.


Business Background

Pluristem Therapeutics Inc is a US-based company which acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. Pluristem operates through the single business segment being Development of placenta-based cell therapy product.

  Be the first to like this.
 


 

2999  2600  389  2989 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FCEL 0.889+0.079 
 CHK 0.69-0.012 
 CSCO 44.91-3.55 
 AMD 38.35+0.83 
 CPE 4.19-0.27 
 AABA 19.630.00 
 NIO 1.75-0.15 
 NOK 3.37-0.10 
 SNNA 0.27+0.11 
 BAC 32.70-0.09 
Partners & Brokers